Global pharmaceutical stocks fell on Monday after President Donald Trump vowed to cut U.S. prescription drug prices to match ...

AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald Trump’s plans to lower drug ...

AstraZeneca's Imfinzi, when combined with standard-of-care BCG induction and maintenance therapy, showed DFS improvement.

At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a ...

Shares in GSK and Astrazeneca slumped on Monday morning after Trump announced a fresh pharma policy that could slash drug ...

Las acciones de las empresas farmacéuticas cayeron en todo el mundo después de que el presidente de EE.UU., Donald Trump, ...

The AstraZeneca share price just took a hit as President Trump announced a price war against the US pharmaceutical industry.

Chegg has gone from being a fast-growth tech stock to a penny share trading for less than $1 in the space of four years. Ben ...

India's generic pharmaceutical industry safeguarded in FTAs with UK and EFTA, rejecting data exclusivity to protect $25 ...

While AI-generated drugs grab headlines, the technology is making more of an impact doing less “glamorous” tasks.

A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...

The price cuts would see that U.S. consumers pay the same amount as the nation that pays the lowest price for that drug.